Literature DB >> 20965148

MELAS syndrome, cardiomyopathy, rhabdomyolysis, and autism associated with the A3260G mitochondrial DNA mutation.

Barbara S Connolly1, Annette S J Feigenbaum, Brian H Robinson, Anne I Dipchand, David K Simon, Mark A Tarnopolsky.   

Abstract

The A to G transition mutation at position 3260 of the mitochondrial genome is usually associated with cardiomyopathy and myopathy. One Japanese kindred reported the phenotype of mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS syndrome) in association with the A3260G mtDNA mutation. We describe the first Caucasian cases of MELAS syndrome associated with the A3260G mutation. Furthermore, this mutation was associated with exercise-induced rhabdomyolysis, hearing loss, seizures, cardiomyopathy, and autism in the large kindred. We conclude that the A3260G mtDNA mutation is associated with wide phenotypic heterogeneity with MELAS and other "classical" mitochondrial phenotypes being manifestations.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20965148     DOI: 10.1016/j.bbrc.2010.10.060

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

Review 1.  Mitochondrial dysfunction can connect the diverse medical symptoms associated with autism spectrum disorders.

Authors:  Richard E Frye; Daniel A Rossignol
Journal:  Pediatr Res       Date:  2011-05       Impact factor: 3.756

Review 2.  Deficits in bioenergetics and impaired immune response in granulocytes from children with autism.

Authors:  Eleonora Napoli; Sarah Wong; Irva Hertz-Picciotto; Cecilia Giulivi
Journal:  Pediatrics       Date:  2014-05       Impact factor: 7.124

3.  Evidence for treatable inborn errors of metabolism in a cohort of 187 Greek patients with autism spectrum disorder (ASD).

Authors:  Martha Spilioti; Athanasios E Evangeliou; Despoina Tramma; Zoe Theodoridou; Spyridon Metaxas; Eleni Michailidi; Eleni Bonti; Helen Frysira; A Haidopoulou; Despoina Asprangathou; Aggelos J Tsalkidis; Panagiotis Kardaras; Ron A Wevers; Cornelis Jakobs; K Michael Gibson
Journal:  Front Hum Neurosci       Date:  2013-12-24       Impact factor: 3.169

Review 4.  Perspectives on Exertional Rhabdomyolysis.

Authors:  Eric S Rawson; Priscilla M Clarkson; Mark A Tarnopolsky
Journal:  Sports Med       Date:  2017-03       Impact factor: 11.136

5.  Autism spectrum disorder: A mitochondrial disorder.

Authors:  Josef Finsterer
Journal:  Iran J Child Neurol       Date:  2021

6.  Toxoplasmosis and Polygenic Disease Susceptibility Genes: Extensive Toxoplasma gondii Host/Pathogen Interactome Enrichment in Nine Psychiatric or Neurological Disorders.

Authors:  C J Carter
Journal:  J Pathog       Date:  2013-03-04

7.  Defective mitochondrial rRNA methyltransferase MRM2 causes MELAS-like clinical syndrome.

Authors:  Caterina Garone; Aaron R D'Souza; Cristina Dallabona; Tiziana Lodi; Pedro Rebelo-Guiomar; Joanna Rorbach; Maria Alice Donati; Elena Procopio; Martino Montomoli; Renzo Guerrini; Massimo Zeviani; Sarah E Calvo; Vamsi K Mootha; Salvatore DiMauro; Ileana Ferrero; Michal Minczuk
Journal:  Hum Mol Genet       Date:  2017-11-01       Impact factor: 6.150

Review 8.  Clinical and Molecular Characteristics of Mitochondrial Dysfunction in Autism Spectrum Disorder.

Authors:  Shannon Rose; Dmitriy M Niyazov; Daniel A Rossignol; Michael Goldenthal; Stephen G Kahler; Richard E Frye
Journal:  Mol Diagn Ther       Date:  2018-10       Impact factor: 4.074

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.